10th May 2007 at 16:46 BST by Dr C.A.Jenner MB BS, FRCA. Permalink.
This article highlights the possible role of botox injections in treating the myofascial pain syndrome (fibromyalgia).
Myofascial Pain Syndrome (MPS) is defined as a painful musculoskeletal condition, characterised by the development of myofascial trigger points (TrPs). The trigger points are locally tender when active and refer pain through specific patterns to other areas of the body.
When pressed upon, a trigger point causes pain that is felt elsewhere in the body, which is further known as referred pain. However, it is important to note that there are no trigger points in Fibromyalgia. Instead, Fibromyalgia is widely accepted as a perpetuating factor of MPS.
In laymen terms, MPS and Fibromyalgia formerly known as fibrositis, is defined as a long-term, body-wide pain in muscles, ligaments and tendons.
There are a vast series of factors that can cause these trigger points to occur. The most important amongst these are:
Some of the most prominent symptoms of Fibromyalgia include:
Botox is basically a drug made from a toxin produced by the bacterium Clostridium botulinum. This toxin is well-known for causing life-threatening type of food poisoning called botulism.
Botox and Dysport are both the trade names of Botulinum toxin, the neurotoxin protein that produces the bacterium. The botox injections are a popular non-surgical treatment used for cosmetic as well as therapeutic purposes.
These injections work mainly by weakening or paralyzing certain muscles or by blocking certain nerves.
The botox injections are commonly used for:
The Myofascial Pain Syndrome is typically characterized by the presence of trigger points that are subject to treatment through the injections of small doses of the Botulinum toxin type A (BTX-A). These produce prolonged muscle relaxation and can be easily targeted at the affected muscles.
A vast number of research reports advocate the use of BTX-A injections in the treatment of the Myofascial Pain Syndrome and Fibromyalgia.
A study was conducted by the Pain Evaluation & Treatment Centre in Tulsa for the purpose. 70 percent of patients with MPS in the back and extremities who received the BTX-A injections over a two year period reported a remarkable pain relief for 2.5 to 3.6 months. The patients were even able to support a therapeutic exercise regimen along with.
Other findings of various studies related to the Myofascial Pain Syndrome being treated with botox include:
For patients who decide to take on the botox injections for relief from the symptoms of myofascial pain syndrome, it is important to keep in the mind the below listed special considerations.
The use of botox injections in the treatment of Myofascial Pain Syndrome and Fibromyalgia requires further research and study to be firmly established. Latest reports in the media and internet are providing a great impetus to the treatment as a miraculous cure for the conditions. However, even though the botox injections can be helpful in treating muscle pain associated with Fibromyalgia, they do not seem to offer any cure for other symptoms of the disorder.
‘Botox and Myofascial Pain Syndrome (Fibromyalgia)’ was posted by Dr C.A.Jenner MB BS, FRCA on 10th May 2007 at 16:46 BST and filed under conditions, fibromyalgia, myofacial pain syndrome, botox and pain.
Subscribe to RSS for Articles . What is RSS?
.jpg)
© London Pain Consultants 2006. Telephone: 0845 045 0250.